Accendra Health, Inc. (ACH)
NYSE: ACH · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Glen Allen, VA · filing with the SEC since 1994
Grade3.0
◀ Past 1.8● Present 3.1▶ Future 3.7
Filings
336 filings since 2017 beside 716 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Oct 29, 2026.
Filings a yearinsider forms included
1131211241121061087560
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 18 times in the last 36 months, the newest Nov 3, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Oct 30, 2026.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Jun 6, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 2, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Oct 29, 2026
Oct 30, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Oct 27, 2026
Oct 9, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Oct 6, 2026
Sep 28, 2026
8-K/A items 5.02, 9.01
Officer or director change · Current report, amended
Sep 16, 2026
Sep 17, 2026
8-K items 5.02, 7.01, 8.01, 9.01
Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Sep 16, 2026
Aug 10, 2026
8-K items 1.01, 3.03, 5.03, 7.01, 9.01
Major agreement signed; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Aug 9, 2026
Aug 10, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 10, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jun 15, 2026
8-K items 1.01, 2.03, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Other event · Current report
Jun 9, 2026
May 15, 2026
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
May 14, 2026
May 11, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 11, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Feb 19, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Jan 5, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Dec 24, 2025
Dec 31, 2025
8-K items 1.01, 2.01, 2.03, 5.02, 5.03, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; New debt or obligation taken on; Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Dec 24, 2025
40 of 336 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.